Clinical Trial Update: Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on non-polymer-based, rapamycin-eluting stents for coronary disease; trial terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease

Drugs mentioned

• Non-polymer-based, rapamycin-eluting stents (rapamycin-eluting stents)

Snippet

Sponsor: Translumina GmbH | Conditions: Coronary Disease | Phase 4 | Status: TERMINATED